Trials / Completed
CompletedNCT02578693
Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)
Long Term Follow-up for Subjects With Chronic Hepatitis C Infection Who Received Interferon-based Therapy or Direct-acting Antiviral Agents (DAAs)-Based Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,210 (actual)
- Sponsor
- Humanity and Health Research Centre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to provide long term clinical and virologic follow up in subjects infected with hepatitis C virus (HCV) who received interferon-based therapy or direct-acting antiviral agents (DAAs)-based therapy. This long term follow up study is observational and no treatment is provided for HCV infection.
Conditions
Timeline
- Start date
- 2015-05-15
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
- First posted
- 2015-10-19
- Last updated
- 2025-03-24
Locations
3 sites across 2 countries: China, Japan
Source: ClinicalTrials.gov record NCT02578693. Inclusion in this directory is not an endorsement.